Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • matteo.cereda
    Junior Member
    • Apr 2018
    • 2

    Postdoc position in Bioinformatics/Cancer Genomics, Turin, Italy

    A Bioinformatics Postdoc position is available in the Cancer Genomics and Bioinformatics Unit of Dr Matteo Cereda at the Italian Institute for Genomic Medicine (IIGM) in Turin (IT). The position is in the context of a national Italian multicenter project (SARGEN-ITA) supervised by Prof Franca Fagioli and supported by the “Associazione Italiana Ematologia Oncologia Pediatrica” (AIEOP).

    Research. The main objective of SARGEN-ITA is identify the molecular underpinnings driving sarcoma onset in young patients. To achieve this goal, our research program will combine genomic, transcriptomic and epigenetic high throughput sequencing approaches (e.g. DNA-, RNA-, ChiP-, ATAC-seq and related methods). Patients will be tracked from the point of diagnosis throughout their treatment with data including longitudinal and multi- tumour site sequencing.

    The research will include (1) applying bioinformatics approaches with longitudinally sampled genomes to track cancer progression and therapy response; (2) identifying molecular markers for use in clinical laboratories; (3) developing a system for linking clinical information, treatment history, cancer genomes and histopathological records of well-characterised tumours;

    Role. The post holder will be involved in the analysis and integration of next generation sequencing data of hundreds of sarcoma tumours. He/she will contribute to the development of algorithms to decipher clonal evolution, intra-sample heterogeneity, driver alterations of these tumours. He/She will design of strategies to identify biomarkers of cancer progression/therapy response. He/she will be responsible for linking genomic data with clinical and treatment information of the patients.

    Candidate. The ideal candidate will have a PhD in computational biology, computer science, engineering, bioinformatics or similar; experience in bioinformatics analyses, especially in the analysis of NGS experiments; analytical and quantitative background and programming skills. Background in cancer genetics is recommended.

    IIGM is a private research institute located in Turin, IT. The institutional goal is to foster and develop excellence in human genomic research and education, with special reference to genomic variability in multifactorial diseases, as cancer. The institute provides high-level scientific education and access to state-of-the-art research facilities (e.g. Illumina, Oxford Nanopore sequencers).

    Application. To apply for this position please submit a cover letter describing research experience and motivation, CV and contact information of 2/3 references to: [email protected]

    The position is available immediately. Salary will vary according to experience.
  • TerryLewis
    Junior Member
    • Nov 2018
    • 6

    #2
    A Bioinformatics Postdoc position is available in the Cancer Genomics and Bioinformatics Unit of Dr Matteo Cereda at the Italian Institute for Genomic Medicine (IIGM) in Turin (IT). The position is in the context of a national Italian multicenter project (SARGEN-ITA) supervised by Prof Franca Fagioli and supported by the “Associazione Italiana Ematologia Oncologia Pediatrica” (AIEOP).

    Research. The main objective of SARGEN-ITA is identify the molecular underpinnings driving sarcoma onset in young patients. To achieve this goal, our research program will combine genomic, transcriptomic and epigenetic high throughput sequencing custom writing approaches (e.g. DNA-, RNA-, ChiP-, ATAC-seq and related methods). Patients will be tracked from the point of diagnosis throughout their treatment with data including longitudinal and multi- tumour site sequencing.

    The research will include (1) applying bioinformatics approaches with longitudinally sampled genomes to track cancer progression and therapy response; (2) identifying molecular markers for use in clinical laboratories; (3) developing a system for linking clinical information, treatment history, cancer genomes and histopathological records of well-characterised tumours;

    Role. The post holder will be involved in the analysis and integration of next generation sequencing data of hundreds of sarcoma tumours. He/she will contribute to the development of algorithms to decipher clonal evolution, intra-sample heterogeneity, driver alterations of these tumours. He/She will design of strategies to identify biomarkers of cancer progression/therapy response. He/she will be responsible for linking genomic data with clinical and treatment information of the patients.

    Candidate. The ideal candidate will have a PhD in computational biology, computer science, engineering, bioinformatics or similar; experience in bioinformatics analyses, especially in the analysis of NGS experiments; analytical and quantitative background and programming skills. Background in cancer genetics is recommended.

    IIGM is a private research institute located in Turin, IT. The institutional goal is to foster and develop excellence in human genomic research and education, with special reference to genomic variability in multifactorial diseases, as cancer. The institute provides high-level scientific education and access to state-of-the-art research facilities (e.g. Illumina, Oxford Nanopore sequencers).

    Application. To apply for this position please submit a cover letter describing research experience and motivation, CV and contact information of 2/3 references to: [email protected]

    The position is available immediately. Salary will vary according to experience.
    Hello Matteo,

    I have a couple of questions. Can it be a remote job? Also: should an applicant know Italian perfectly well? I'm wondering about the salary ranges (how it depends on the experience). Thank you.

    Dr. Terry Lewis
    Last edited by TerryLewis; 04-11-2019, 10:34 PM. Reason: questions

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    34 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    25 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    217 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    81 views
    0 reactions
    Last Post SEQadmin2  
    Working...